官方服务：
资源简介：
DNA-targeted platinum-acridine anticancer agents
应用场景：
创建时间：
2012-08-28
相关数据集
North America DNA Medicine Based on DNA Modification Market
The North America DNA Medicine Based on DNA Modification market report offers a thorough competitive analysis, mapping key players’ strategies, market share, and business models. It provides insights
IMR REPORTS40
Curcumin Analog DM-1 in Monotherapy or Combinatory Treatment with Dacarbazine as a Strategy to Inhibit In Vivo Melanoma Progression
Malignant melanoma is a highly aggressive form of skin cancer with a high mortality rate if not discovered in early stages. Although a limited number of treatment options for melanoma currently exist,
Figshare2016-01-15 更新20
Supplementary Table from Decreased DNA Damage and Improved p53 Specificity of RITA Analogs
Supplementary Table from Decreased DNA Damage and Improved p53 Specificity of RITA Analogs
NIAID Data Ecosystem10
Azolylpyrimidinediols as Novel Structural Scaffolds of DNA-Groove Binders against Intractable Acinetobacter baumannii
A unique class of antibacterial azolylpyrimidinediols (APDs) and their analogues were developed. Some synthesized compounds showed excellent bacteriostatic potency; especially, triazolylpyrimidinediol
NIAID Data Ecosystem30
Ruthenium(II)–Tris-pyrazolylmethane Complexes Inhibit Cancer Cell Growth by Disrupting Mitochondrial Calcium Homeostasis
While ruthenium arene complexes have been widely investigated for their medicinal potential, studies on homologous compounds containing a tridentate tris(1-pyrazolyl)methane ligand are almost absent
NIAID Data Ecosystem20
